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Objective: Eye movement desensitization and reprocessing (EMDR)—an evidence- 
based approach to eliminate emotional distress from traumatic experiences—was 
recently suggested for the treatment of chronic pain. The aim of this study was to 
estimate preliminary efficacy of a pain-focused EMDR intervention for the treatment of 
non-specific chronic back pain (CBP).
Design: Randomized controlled pilot study.
Methods: 40 non-specific CBP (nsCBP) patients reporting previous experiences of 
psychological trauma were consecutively recruited from outpatient tertiary care pain 
centers. After baseline assessment, patients were randomized to intervention or control 
group (1:1). The intervention group received 10 sessions standardized pain-focused 
EMDR in addition to treatment-as-usual (TAU). The control group received TAU alone. 
The primary outcome was preliminary efficacy, measured by pain intensity, disability, 
and treatment satisfaction from the patients’ perspective. Clinical relevance of changes 
was determined according to the established recommendations. Assessments were 
conducted at the baseline, posttreatment, and at a 6-month follow-up. Intention-to-treat 
analysis with last observation carried forward method was used. Registered with http://
ClinicalTrials.gov (NCT01850875).
results: Estimated effect sizes (between-group, pooled SD) for pain intensity and dis-
ability were d = 0.79 (CI95%: 0.13, 1.42) and d = 0.39 (CI95%: −0.24, 1.01) posttreatment, 
and d = 0.50 (CI95%: 0.14, 1.12) and d = 0.14 (CI95%: −0.48, 0.76) at 6-month follow-up. 
Evaluation on individual patient basis showed that about 50% of the patients in the 
intervention group improved clinically relevant and also rated their situation as clinically 
satisfactory improved, compared to 0 patients in the control group.
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inTrODUCTiOn
Chronic back pain (CBP) is common and of socioeconomic 
relevance (1, 2). For the individual patient, CBP is associated 
with serious disability and reduced quality of life [e.g., Ref. (1, 
3)]. However, for approximately 90% of individuals with CBP, 
there is no identifiable structural cause (1, 4); these individuals 
are typically referred to as having non-specific CBP (nsCBP).
Although there are many approaches to treating nsCBP, unfor-
tunately, treatment in these patients has often limited success 
(5–7) and fails to meet patients’ success criteria (8, 9). This might 
be the case because many of nsCBP patients report high emotional 
distress (10–13), but particularly for nsCBP patients with high 
degrees of emotional distress, classic pain-psychotherapeutic 
approaches are often insufficient (14). One explanation might be 
that psychotherapeutic attention paid to patients affected by pain 
had long focused mainly on cognitive-behavioral factors such 
as dysfunctional coping strategies and maladaptive behavioral 
patterns (14). This neglected the fact that emotional distress, e.g., 
caused by psychological trauma, can also have a central impact 
on the sensation and processing of pain (15–17). It is well known 
that physical pain alongside the purely sensory experience of pain 
generally also comes with a significant emotional dimension (17, 
18). This emotional dimension not only influences fundamental 
aspects such as how severe or distressing a pain is felt to be but 
also significantly influences the persistence of the pain symptoms 
(19, 20). Recent studies show that in the context of pain chroni-
fication, there is a shift away from the classic pain-processing 
regions in the brain toward the emotional networks (21). This 
emotional shift is blamed for the fact that pain may persist in 
patients with high emotional distress (21). The acknowledgment 
that pain can become chronic through maladaptive emotional 
processing forms the pathophysiological basis for applying eye 
movement desensitization and reprocessing (EMDR) (22) in 
treating chronic pain.
Eye movement desensitization and reprocessing is a psycho-
therapeutic approach that was originally developed to eliminate 
emotional distress resulting from traumatic memories. The EMDR 
intervention follows a standardized treatment protocol (22) and 
aims to process dysfunctionally stored disturbing memories and 
associated cognitions, emotions, and physical sensations (e.g., 
pain). EMDR has now become an empirically validated and 
recommended first-line treatment for posttraumatic stress disor-
ders (PTSD) and other conditions that are specifically related to 
(emotional) stress [e.g., Ref. (23–26)]. The EMDR intervention, 
as an established procedure for exposing emotional response 
from trauma therapy, can be used specifically to process emo-
tional distress in patients suffering from chronic pain with the 
clear objective of processing this dysfunctional emotional shift.
Therefore, preliminary studies (case reports and case series) 
have used EMDR to treat chronic pain and have indicated that 
EMDR is able to clinically significantly reduce pain intensity 
and disability in patients with various pain disorders (27). 
Furthermore, EMDR improves pain-coping abilities and facili-
tates relaxation, which reduces pain and pain-related attitudes 
and beliefs (28). Therefore, EMDR treatment is a promising 
approach for nsCBP patients, where psychosocial factors seem 
to be of special significance (e.g., patients with psychological 
trauma). However, although nsCBP is one of the most frequent 
types of pain, only one case series used EMDR for nsCBP. This 
case series showed that EMDR is able to clinically reduce pain 
intensity and pain interference in nsCBP patients (29).
Therefore, we developed an EMDR manual for nsCBP patients 
(30) and conducted a randomized controlled pilot study of 
10-session manualized outpatient pain-focused EMDR treatment 
for nsCBP patients with previous experience of psychological 
trauma (nsCBP-t). The objective was to estimate preliminary 
efficacy of a pain-focused EMDR intervention in addition to 
treatment-as-usual (TAU) compared to TAU alone in nsCBP-t 
patients. Outcomes were pain intensity, disability, and patients’ 
global impression of change (patient success criteria). In addi-
tion, we explored the feasibility (acceptability of randomization, 
adequate retention rate, and recording of negative effects) to 
conduct a larger trial.
MaTErialS anD METHODS
Study Design
The study was a mono-center, single-blind (outcome assessor), 
and two-group parallel randomized controlled pilot study of 
adult patients with nsCBP-t. The study design has been published 
elsewhere (31), and the trial protocol was registered with http://
ClinicalTrials.gov (NCT01850875). The study was part of the 
research consortium LOGIN, funded by the German Federal 
Ministry of Education and Research (01EC1010A) (32). Ethics 
approval was received from the Ethics Committee Heidelberg 
(approval No. S-261/2010), and the study was conducted in 
accordance with the Declaration of Helsinki in its present form. 
All the participants provided written informed consent.
Participants
Participants were consecutively recruited (April 2013 to 
December 2014) from a specialized outpatient clinic for chronic 
pain disorders at the Department of General Internal Medicine 
and Psychosomatics of the University Hospital Heidelberg.
The inclusion criteria were as follows: presence of nsCBP, 
≥18  years, adequate German language skills, and previous 
Conclusion: There is preliminary evidence that pain-focused EMDR might be useful 
for nsCBP patients with previous experiences of psychological trauma, with benefits for 
pain intensity maintained over 6 months.
Keywords: chronic back pain, eye movement desensitization and reprocessing, psychological trauma, treatment
3Gerhardt et al. EMDR in Chronic Back Pain
Frontiers in Psychiatry | www.frontiersin.org December 2016 | Volume 7 | Article 201
exposure to at least one psychologically traumatic event. The 
exclusion criteria were as follows: application for retirement 
pension pending, ongoing psychotherapy, severe dissociation (as 
dissociation is a known contraindication for EMDR), and severe 
comorbidity or disorders requiring inpatient care (e.g., anorexia 
nervosa or severe psychiatric comorbidity).
To confirm the diagnosis of nsCBP, all patients received a 
physical examination (general, rheumatological, orthopedic, and 
neurological), with special attention paid to findings that indi-
cated a specific origin of back pain. Therefore, “red flags” [hints 
of the presence of serious pathology according to the Agency for 
Health Care Policy and Research Low Back Guidelines (33)] were 
considered, and attention was paid to the German guidelines for 
the management on back pain (34). Furthermore, former medi-
cal reports and discharge letters were taken into account when 
available, and all the patients were questioned about their past 
medical history and their comorbidities. In cases with signs of 
serious pathological findings, participants were excluded from 
the current study. Chronicity of back pain was defined as at least 
45 days with back pain within the last 3 months. Clinical evalua-
tion was carried out by two physicians with extensive experience 
with the diagnosis and management of chronic pain conditions, 
especially musculoskeletal pain.
The experience of psychological trauma was assessed by the 
Structured Clinical Interview for the Diagnostic and Statistical 
Manual for Mental Disorders (35). As EMDR is specifically 
directed to eliminate emotional distress that results from trau-
matic events, we focused on psychological trauma from specific 
events. The legal definition of emotional distress states that severe 
emotional distress exists where a reasonable person normally con-
stituted would be unable to cope adequately with the mental stress 
engendered by the circumstances of the event (36). Therefore, 
patients who experienced, witnessed, or were confronted with an 
event that was accompanied by the involvement of strong nega-
tive emotions such as intense fear, helplessness, or horror were 
classified as subjects having experienced psychological trauma.
The exclusion criteria dissociation was measured by the FDS-
20, a German adaption of the Dissociative Experience Scale (37). 
Patients with scores >12 were excluded.
randomization, Masking, and 
Methodological aspects
Patients who were eligible and provided written informed consent 
to participate were enrolled in the study, and baseline data were 
collected. After acquisition of baseline data, participants were 
randomly assigned (blocked randomization, 1:1, block length 
4) to the intervention group (TAU + EMDR) or control group 
(TAU only). An independent person randomized each patient 
using a computer-based system and mailed a fax to the group of 
therapists.
The outcome assessor (study nurse) was not involved in 
treatment or randomization and thus was blinded in regard to 
group membership. Data were managed and analyzed by Andreas 
Gerhardt.
The EMDR treatment was provided by EMDR-trained physi-
cians (Susanne Janke and Jonas Tesarz) and an EMDR-trained 
psychologist (Sabine Leisner) who had participated in an EMDR 
International Association (EMDRIA)-approved basic training 
program. The therapists were supervised regularly (at least two 
times per patient) by an EMDRIA-approved consultant (Günter 
H. Seidler). Before starting the study, a treatment manual was 
developed to guarantee standardized treatment (30). Each thera-
pist underwent 3-day training on the manual.
Because this was a pilot study, there was no formal sample size 
calculation. Therefore, estimated effect sizes must be considered 
as preliminary. Funding was granted for 20 patients in each study 
group.
interventions
All the participants (intervention and control group) received 
TAU. TAU was a treatment approach following the German 
disease management guideline “low back pain” (34). This guide-
line gives structured clinical decision-making aids for providing 
evidence-based medical care in the German health-care system. 
This may include patient education, general support and advice, 
physiotherapy, and simple analgesics according to symptoms. 
TAU was delivered by our tertiary care pain center and the 
patients’ general practitioners.
Participants who were allocated to the intervention group 
received, in addition to TAU, a manualized and 10-session out-
patient psychotherapeutic EMDR intervention (every 2  weeks 
for 90 min). Treatment was delivered at the University Hospital 
Heidelberg. The treatment manual (30) that was developed for 
this study was based on the principles of EMDR standard pro-
cedure (22) and incorporated established EMDR pain protocols 
focusing on chronic pain patients (28, 38).
The EMDR procedure combines the use of well-established 
psychotherapeutic methods (including imaginal exposure and 
cognitive and self-control techniques) and the use of specific 
EMDR elements such as bilateral sensory stimulation (e.g., 
left–right eye movements or bilateral hand-tapping induced 
by the therapist’s fingers) and the dual focus of attention prin-
ciple (39). With the dual focus of attention principle, patients 
simultaneously focus on distressing memories and an external 
bilateral sensory stimulus. This EMDR procedure is suggested 
to facilitate information processing of emotionally distressing 
memories (e.g., traumatic events or pain sensations) and thereby 
cause a decreasing or even an elimination of the emotional dis-
tress related to these memories. The goal of EMDR is to greatly 
decrease or eliminate emotional distress related to a specific 
memory (“target”). This typically results in modifications of pain, 
mood, behavior, and improved coping abilities (28). The possible 
targets for EMDR processing were disturbing memories, cur-
rent pain perceptions, and anticipated future painful situations 
together with the associated cognitions, emotions, and bodily 
sensations.
According to the study manual (30), the EMDR condition 
started with two sessions dedicated to treatment planning and 
preparation (including comprehensive assessment of the patient’s 
history to identify relevant traumatic and pain-related memories 
causing emotional distress and dysfunctional emotional response, 
discussing the patient’s explanatory model, and subsequently 
providing psychoeducation to develop a better understanding 
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of the links between trauma, pain, emotional response, and the 
principles of EMDR).
The preparatory sessions were followed by seven desensitizing 
and reprocessing sessions, started by desensitizing and reprocess-
ing the emotionally most distressing memories; afterward, all 
pain-associated memories of subsequent events were focused 
until the subjective degree of distress of these memories dropped 
down. After distressing memories and thoughts were processed, 
current pain sensations were focused. In the last session (session 
10), future pain issues as future pain crises or potential pain triggers 
were targeted by installation and reinforcement of EMDR-based 
skills to cope with future distressing or painful events. According 
to the standard EMDR procedure, each EMDR session was struc-
tured as follows: each session started with a 15-min introduction 
during which patients were asked about their experiences of 
the last session and the course since the last session. Afterward, 
the patient was instructed to recognize a picture that represents 
the most distressing part of the chosen memory, a negative 
unreasonable self-belief related to the picture, a positive adaptive 
cognition, as well as the related emotions and the associated body 
sensations. Thereupon, the patient was guided to focus on the 
chosen picture and related feelings/affects, cognitions, and body 
sensations in brief sequential sets while simultaneously focusing 
on the external bilateral sensory stimulus given by the therapist. 
After each set, the patient reported any new associations and body 
sensations that may have emerged. Such associations and body 
sensations, generally, became the focus of the next set of double 
attention. This procedure continued until the target memory 
and/or unpleasant body sensation was desensitized. After that, 
more bilateral sensory stimulation was used, while the patient 
was thinking of a recognized adaptive belief or pleasant body 
sensation. This was repeated until the new statement felt proper 
to the patient and until all physical discomfort was dissipated.
If the processing of the traumatic or pain-related distressing 
event was not completed in a single session, the last 5–10 min 
of each session were used to assist the patient in returning to a 
more secure and balanced mental state in using an individual 
self-calming or relaxation techniques that were designed to bring 
emotional stability and tranquility. The control group received no 
specific treatment in addition to TAU.
Measures
Age, sex, partnership status, education, working status, history of 
back pain, days with pain within the last 4 weeks, and medication 
were captured by a questionnaire. Adverse and severe adverse 
events were documented.
Outcome Measures
The primary outcome was preliminary efficacy of EMDR treat-
ment after 10 treatment sessions (about 6  months). Following 
established recommendations for outcome measures in clinical 
chronic pain trials and recommendations for interpreting clini-
cal importance and the clinical importance of group differences 
[Initiative on Methods, Measurement, and Pain Assessment in 
Clinical Trials, IMMPACT (40–43)], we measured pain intensity, 
disability, and patients’ global impression of change due to treat-
ment. We also determined proportion of patients with clinically 
relevant changes according to the established recommenda-
tions. To measure outcomes, we used instruments suggested by 
IMMPACT (40).
To assess the primary outcome, participants completed a ques-
tionnaire after inclusion in the study and before randomization 
and treatment allocation (T0: baseline) and 2 weeks after study 
completion (T1: after treatment, primary endpoint; at average 
6 months after T0). There was also a follow-up 6 months after the 
end of treatment (T2, see below).
Pain intensity: mean pain intensity within the past 
4  weeks was measured using the Numerical Rating 
Scale (NRS), which ranges from 0 “no pain” to 10 “worst 
pain imaginable.” We also determined number of indi-
viduals in the intervention group with clinical relevant 
reductions (≥30% =  clinically moderately important; 
≥50% = substantial change) (41). The NRS is a valid and 
reliable 1-item instrument that is sensitive to change 
(44, 45) and recommended by IMMPACT (40).
Disability: the German version of the West Haven-Yale 
Multidimensional Pain Inventory (MPI-D) was used 
to assess pain-related life interference (46, 47). The 
subscale consists of 10 questions regarding different 
aspects of daily life (e.g., interference in social activities, 
work, daily activities, household chores, family activi-
ties) that are rated on a 7-point scale ranging from 0 
“no interference” to 6 “extreme interference.” For the 
interference score, the mean of the 10 items was used 
(0–6). We also determined the number of individuals 
in the intervention group with a clinical meaningful 
change (improvement of ≥0.6) (41). The MPI-D is a 
reliable and valid instrument (46, 47). Cronbach’s α in 
the current study was excellent (αT0 = 0.93, αT1 = 0.95). 
The MPI is recommended by IMMPACT (40).
Patients’ perspective of change: global ratings of change 
of the overall situation due to treatment was evaluated 
using the Patient Global Impression of Change (PGIC) 
scale, which is a single-item rating on a 7-point scale 
ranging from “very much improved” to “very much 
worse” (48). Changes of “much improved” and “very 
much improved” are considered as clinically relevant 
(41). The PGIC is recommended by IMMPACT (40).
The secondary outcome was feasibility for conducting a larger 
trial, which was defined as follows: acceptability of randomization 
≥80%, retention rate ≥80% in the intervention group (including 
complete data at end of intervention), and safety. Safety was 
defined as no recordings of important negative effects (e.g., pain 
intensity after EMDR intervention >pain intensity before EMDR 
intervention).
We determined group differences between intervention group 
and control group at T1. Data at T2 were compared exploratively.
Statistical analyses
All collected data were analyzed using SPSS for Windows 22.0 
(SPSS, Inc., Chicago, IL, USA). We analyzed the full analysis 
set according to the intention-to-treat approach using the last 
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observation carried forward method. Descriptive statistics are 
presented as means (M) and SDs for continuous variables and 
absolute numbers (N) and percentages for categorical variables. 
Independent t-tests were used for the comparison of between-
group differences for continuous variables, and Fisher’s exact 
test was used for between-group comparisons of categorical data 
(baseline data). For the primary outcome, preliminary effect 
sizes and their 95% confidence interval were calculated using 
Cohen’s d for continuous variables (between-group effect sizes, 
pooled SD). In addition, exploratory data analysis that calculated 
appropriate summary measures for empirical distribution was 
performed, and descriptive two-sided P-values were calculated. 
Between-group differences—scores at T1 and T2—were analyzed 
using independent t-tests.
With regard to secondary endpoint, feasibility, acceptability of 
randomization, and retention rate were reported descriptively. In 
addition, negative effects of treatment were reported.
rESUlTS
We screened 172 patients for eligibility. The main exclusion 
criterion was the lack of reporting psychological trauma. 
Acceptability of randomization was 91%. Finally, 40 patients 
underwent randomization after baseline assessment (T0). Twenty 
patients were randomized to the intervention group and 20 to the 
control group. At T1, two patients in the intervention group and 
three in the control group had dropped out of the study (dropout 
rates were 10.0 and 15.0%, respectively). Thus, the retention rate 
was 90.0% in the intervention group (including complete data at 
the end of the intervention) and 85.0% in the control group. The 
two dropouts in the intervention group occurred within treat-
ment session 2 due to time constraints and diagnosis of cancer, 
respectively. In the control group, two patients refused T1 evalua-
tion because of time constraints, and a third patient could not be 
contacted. In the intervention group, all patients who completed 
the study attended all the 10 treatment sessions, indicating good 
treatment adherence. The participation flow chart is presented 
in Figure 1.
Considering adverse events, the most frequently reported side 
effects were intense pain during EMDR treatment and short-term 
increases in pain and tiredness directly following the sessions. 
These symptoms disappeared after the treatment session or 
within the following hours. No increases in medication or severe 
adverse events were reported during the course of treatment.
Baseline assessment
All patients were Caucasian. Twenty-eight (70%) patients 
were females and 12 (30%) were males. Age ranged from 37 to 
71 years (M = 56.6, SD = 8.0). The patients suffered from pain 
for 2 years up to 50 years, with most patients suffering from pain 
for >10 years. There was no statistical significant difference for 
any of the baseline variables (age, gender, status of partnership, 
education, working status, days with pain, pain intensity, history 
of CBP, number of painful areas, interference, and medication) 
between the study groups. For the baseline data (sociodemo-
graphic data and pain measures) of the intervention group and 
control group, see Table 1.
Considering medication, approximately half of the patients 
in both groups used pain medication, mostly on demand. Two 
patients in the control group used long-term medication, one used 
tapentadol (opioid) and one used ibuprofen (non-steroidal anti-
inflammatory drug). Medications on demand were non-steroidal 
anti-inflammatory drugs (diclofenac, ibuprofen, and aspirin) and 
non-acidic analgesics (acetaminophen and metamizole). One 
patient in the intervention group used a centrally acting non-
opioid analgesic (flupirtine) on demand. There was no significant 
group difference for any of the measured variables at baseline (T0).
Primary Outcome: Between-Group 
Comparisons at Posttreatment (T1)
Pain Intensity: the test of group differences at T1 between 
the intervention group and control group revealed a 
moderate to large estimated effect size (d = 0.79; CI95%: 
0.13, 1.42). According to recommendations, nine (45%) 
patients in the intervention group could be classified 
as clinically relevant improved (improvement ≥30%). 
Of these, seven showed a substantial (≥50%) and two a 
moderate improvement (≥30%) (41).
Disability: the test of group difference at T1 revealed 
a moderate effect size (d =  0.39, CI95%: −0.24, 1.01). 
According to the established recommendations, 10 
patients (50%) in the intervention group could be clas-
sified relevant improved with a decrease of at least 0.6 
points (41).
Treatment satisfaction from the patients’ perspective: 10 
patients (50.0%) in the intervention group rated their 
overall alterations during the study phase as much 
improved (n = 8) or very much improved (n = 2). In the 
control group, there were no patients who rated their 
satisfaction as much or very much improved (d = 1.69, 
CI95%: 0.94, 2.38).
For an overview of primary outcomes (T1), see Table 2.
Considering TAU, patients in the control group had on 
average 6.0 additional appointments until T1 compared to 3.0 
appointments in the intervention group (in addition to the initial 
appointment in our tertiary care pain center at T0). Most often, 
patients were prescribed physiotherapy (40 vs. 15%) and massage 
(35 vs. 25%) with higher rates in the control group compared to 
the intervention group.
6-Month Follow-up: Between-Group 
Comparisons (T2)
Pain intensity: the test of group differences at T2 
between the intervention group and control group 
revealed a moderate estimated effect size (d =  0.50; 
CI95%: 0.14, 1.12). According to recommendations, 
13 (65%) patients in the intervention group could be 
classified as responders (improvement ≥30%). Of these, 
five showed a substantial (≥50%) and eight a moderate 
improvement (≥30%) (41).
FiGUrE 1 | Participation flow. EMDR, eye movement desensitization and reprocessing; T0, baseline assessment; T1, assessment after intervention; T2, 6-month 
follow-up assessment.
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Disability: the test of group difference at T2 revealed a 
small effect size (d = 0.14, CI95%: −0.48, 0.76). According 
to the established recommendations, 7 patients (35%) 
in the intervention group could be classified as respond-
ers with a decrease of at least 0.6 points (41).
Treatment satisfaction from the patients’ perspective: 
eight patients (40.0%) in the intervention group rated 
their overall alterations during the study phase as much 
improved (n = 4) or very much improved (n = 4). In the 
control group, there were no patients who rated their 
satisfaction as much or very much improved (d = 1.21, 
CI95%: 0.51, 1.86).
For details, see Table 3.
In addition to the appointment at T1 in our tertiary care pain 
center that was used to adjust TAU, until T2 the control group 
had on average 11 additional appointments compared to 10 
appointments in the intervention group. Considering specific 
interventions, 80 vs. 55% engaged in physiotherapy, 55 vs. 20% 
in massage, and 45 vs. 10% in psychotherapy for control group 
compared to intervention group, respectively. This shows that 
in the control group, more often interventions were prescribed. 
Moreover, although almost half of the patients in the control 
group started with psychotherapy, there was a moderate effect 
of EMDR intervention compared to the control group in favor 
of EMDR.
DiSCUSSiOn
In this study, we describe the results of a manualized, 10-ses-
sion EMDR intervention for the treatment of nsCBP-t patients. 
Comparisons of pain intensity and disability after treatment 
between the intervention and control group suggested improve-
ments in the intervention group with moderate to large effect sizes. 
As recommended, complementary to analysis of between-group 
effects, we also analyzed the individual response to treatment 
(42). Our results demonstrated a clinical relevant improvement 
in pain intensity in nine (45%) patients of the intervention 
TaBlE 3 | Pain assessment and psychological variables after 6-month follow-up (T2).
intervention group Control group T/Chisq DF P d
Number of subjects 20 20
Days with pain last 4 weeks (0–28), M ± SD 23.95 ± 8.64 24.55 ± 7.10 0.240 38 0.812 0.08
CBP intensity (NRS 0–10), M ± SD 3.80 ± 2.24 4.90 ± 2.17 1.574 38 0.124 0.50
MPI interference (0–6), M ± SD 2.19 ± 1.60 2.40 ± 1.34 0.447 38 0.658 0.14
Patient Global Impression of Change (1–7), M ± SD 2.74 ± 1.24 3.94 ± 0.66 3.691 34 0.001 1.21
T/Chisq, test statistic; DF, degrees of freedom; P, P-values; d, Cohen’s d (positive effect sizes indicate better outcome in intervention group); M, mean; CBP, chronic back pain; NRS, 
Numerical Rating Scale.
TaBlE 2 | Pain assessment and psychological variables after treatment (T1).
intervention group Control group T/Chisq DF P d
Number of subjects 20 20
Days with pain last 4 weeks (0–28), M ± SD 23.60 ± 8.01 25.50 ± 5.42 0.878 38 0.386 0.28
CBP intensity (NRS 0–10), M ± SD 3.88 ± 2.15 5.45 ± 1.82 2.499 38 0.017 0.79
MPI interference (0–6), M ± SD 2.09 ± 1.44 2.70 ± 1.65 1.246 38 0.220 0.39
Patient Global Impression of Change (1–7), M ± SD 2.63 ± 1.07 4.18 ± 0.73 5.307 34 0.000 1.69
T/Chisq, test statistic; DF, degrees of freedom; P, P-values; d, Cohen’s d (positive effect sizes indicate better outcome in intervention group); M, mean; CBP, chronic back pain; NRS, 
Numerical Rating Scale.
TaBlE 1 | Sociodemographic characteristics, pain assessment, and psychological variables at baseline (T0).
intervention group Control group T/Chisq DF P
Number of subjects 20 20
Age, M ± SD 56.65 ± 8.88 56.45 ± 7.28 −0.078 38 0.938
Female sex, % 14 (70%) 14 (70%) 0.000 1 1.000
Partnership (firm relationship), N (%) 14 (70%) 17 (85%) 1.290 1 0.451
Education (>10 years in school), N (%) 6 (30%) 9 (45%) 0.960 1 0.514
Working status, N (%)
Employed 13 (65%) 12 (60%) 1.264 3 1.000
Unemployed 0 (0%) 1 (5%)
Retired 6 (30%) 6 (30%)
Others 1 (5%) 1 (5%)
Pain assessment
Days with pain last 4 weeks (0–28), M ± SD 26.95 ± 4.70 25.95 ± 5.13 −0.643 38 0.524
CBP intensity (NRS 0–10), M ± SD 4.93 ± 2.41 5.65 ± 1.66 1.108 38 0.275
History of CBP, N (%)
<1 year 0 (0%) 1 (5%) 1.039 2 1.000
1–10 years 8 (40%) 7 (35%)
>10 years 12 (60%) 12 (60%)
Number of painful areas (0–10), M ± SD 6.45 ± 2.31 5.70 ± 1.75 −1.159 38 0.254
MPI interference (0–6), M ± SD 2.83 ± 1.57 2.98 ± 1.38 0.324 38 0.747
Pain medication, N (%) 11 (55%) 11 (55%) 0.000 1 1.000
T/Chisq, test statistic; DF, degrees of freedom; P, P values; M, mean; CBP, chronic back pain; NRS, Numerical Rating Scale; MPI, West Haven-Yale Multidimensional Pain Inventory.
7
Gerhardt et al. EMDR in Chronic Back Pain
Frontiers in Psychiatry | www.frontiersin.org December 2016 | Volume 7 | Article 201
group. Considering disability, a clinical important improvement 
was reported in 10 (50%) of the patients. These results are in 
accordance with patients’ subjective rating of global impression 
of change in our study because 10 (50%) patients in the interven-
tion group rated their overall situation as clinically satisfactorily 
improved compared to 0 patients in the control group. Thus, it 
seems that EMDR treatment for nsCBP-t, which directly focuses 
on disturbing pain-related memories, associated memories, 
current pain perception, or anticipated stressful situations, may 
be a new, promising, and emerging treatment that is suitable for 
nsCBP-t patients.
To our knowledge, except a small case series (29), the current 
study is the first to suggest that EMDR-based treatment may 
successfully reduce pain intensity and pain-related disability in 
patients with nsCBP-t. The improvements in our study occurred 
despite preceding, long-standing histories of treatment-refractory 
pain. Moreover, our data indicated that EMDR treatment seems 
to be a safe and brief approach.
Although a clinically relevant improvement was suggested 
in about 50% of the patients in the intervention group, this 
was not the case for the other 50%. In a larger randomized 
controlled trial, prognostic variables for responders should be 
identified to foster the allocation of patients to treatment that 
is appropriate for them. Because existing treatments only have 
low to moderate effects (5–7) and fail to meet patients’ success 
criteria (8, 9), our results are promising because the treatment 
seemed to meet patients’ success criteria and clinically relevant 
changes were suggested for half of the treated patients. However, 
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due to our pilot study design, results should be interpreted with 
caution.
Explorative 6-month follow-up suggests maintained 
improvements in pain intensity by EMDR intervention. The 
effect was smaller than directly after treatment, what might 
be the case because almost half of the patients in the control 
group started psychotherapeutic treatment during follow-up. 
The moderate effect for disability, however, attenuated to small 
or negligible size. These findings suggest the implementation of 
subsequent booster sessions that might be helpful to sustain the 
achieved effects after treatment. Considering clinical relevance 
on individual patient basis, after 6-month follow-up, 13 (65%) 
and 7 (35%) of the patients in the intervention group showed 
relevant improvement in pain intensity and disability, respec-
tively. Eight (40%) of the patients in the intervention group rated 
the improvement as clinically relevant from their perspective. 
This suggests that treatment might be especially successful in a 
subgroup of nsCBP-t patients who should be identified in future 
research.
The preliminary hints for the success of EMDR treatment for 
some of the nsCBP-t patients give rise to the question of what 
mechanisms are responsible for these effects. Several possible 
explanations for the mechanism underlying pain reduction by 
EMDR are discussed. Recent studies show that in the context 
of pain chronification in the brain, there is a shift away from 
the classic pain-processing regions of the brain and toward the 
emotional networks of the brain (21). EMDR, as an established 
procedure for exposing emotional response from trauma therapy, 
is suggested to specifically process this dysfunctional emotional 
shift (49, 50). In addition to this, EMDR-specific elements of 
desensitization and reprocessing of emotional distress induce 
some psychophysiological de-arousal (51, 52). EMDR also con-
tains numerous other pain-relief therapeutic elements that are 
not specific to EMDR [e.g., exposure, relaxation, and hypnotic 
techniques as well as improved coping abilities (28, 53)]. The 
assumption of an improved ability to cope with pain is consist-
ent with the observed reduction of pain-related disability in this 
study. Therefore, more research on the involved mechanisms and 
their convertibility by treatment is necessary to examine the ques-
tion of underlying mechanisms.
However, there are some potential study limitations that might 
have biased our results. First, as common for pilot studies, the 
study was not sufficiently powered for confirmatory decisions 
about efficacy of EMDR in nsCBP-t patients. Moreover, EMDR 
was not compared to other psychotherapeutic treatments. 
However, these limitations were accepted fitting with our proof 
of concept pilot RCT design that was not confirmatory but aimed 
at a first impression of potential effects of EMDR in nsCBP-t. 
Therefore, these first results considering EMDR in nsCBP-t have 
to be replicated with larger, methodological, and more stringent 
trials.
Although there are some shortcomings, our study is important 
because we were the first to use EMDR with nsCBP-t patients 
and applied a more stringent research design than previous stud-
ies (e.g., homogeneous patient groups, randomization, control 
group, standardized treatment protocols). The effects reported 
in our study suggested also that EMDR treatment may satisfy 
patients’ success criteria and may offer sufficient pain relief for 
nsCBP-t patients. Moreover, although patients reported previous 
traumatic events, treatment was mainly pain focused. Although 
our results are preliminary and should be interpreted with cau-
tion, our study will facilitate research on this topic.
COnClUSiOn
Our study suggests that our EMDR manual may be safe and 
seems to achieve clinically relevant reductions in pain intensity 
and disability in nsCBP-t patients who seem to be rated relevant 
by the patients. For pain intensity, the effect decreased within 
6-month follow-up but was suggested to be further moderate and 
relevant. Thus, EMDR may be a promising treatment for nsCBP-t. 
Nevertheless, these preliminary results must be interpreted with 
caution. In the next step, a methodologically more stringent RCT 
on EMDR in nsCBP-t with an appropriate sample size and a 
psychosocial comparator intervention is necessary to underpin 
and confirm our findings. If so, in addition, identification of 
responders and non-responders is desirable to allocate patients 
to appropriate treatments. The results will be important in deter-
mining whether routine use of EMDR therapy for nsCBP-t and 
nsCBP patients in general is indicated.
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